XML 31 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements
9 Months Ended
Sep. 30, 2013
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements
The Company measures its financial assets and liabilities at fair value on a recurring basis using a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies. The three levels of inputs used to measure fair value are as follows:
Level 1 — Valuations based on quoted prices for identical assets and liabilities in active markets.
Level 2 — Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.
Level 3 — Valuations based on unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.
Financial assets and liabilities measured at fair value on a recurring basis and presented in the Company's condensed consolidated balance sheets are as follows:
 
September 30, 2013
 
Total
 
Level 2
 
Level 3
Assets
 
 
 
 
 
Foreign currency forward contracts
$
25

 
$
25

 
$

Total financial assets
$
25

 
$
25

 
$

 
 
 
 
 
 
Liabilities
 
 
 
 
 
Foreign currency forward contracts
$
1,323

 
$
1,323

 
$

Contingent consideration liabilities
2,206

 

 
2,206

Total financial liabilities
$
3,529

 
$
1,323

 
$
2,206

 
December 31, 2012
 
Total
 
Level 2
 
Level 3
Assets
 
 
 
 
 
Foreign currency forward contracts
$
31

 
$
31

 
$

Total financial assets
$
31

 
$
31

 
$

 
 
 
 
 
 
Liabilities
 
 
 
 
 
Foreign currency forward contracts
$
433

 
$
433

 
$

Contingent consideration liabilities
1,990

 

 
1,990

Total financial liabilities
$
2,423

 
$
433

 
$
1,990


Refer to Note A for further information regarding derivative instruments and Note B for further information regarding contingent consideration liabilities.